Horizant

Product manufactured by Arbor Pharmaceuticals

Application Nr Approved Date Route Status External Links
NDA022399 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Horizant Is Indicated For: Treatment Of Moderate-To-Severe Primary Restless Legs Syndrome (Rls) In Adults. ( 1.1 ) Management Of Postherpetic Neuralgia (Phn) In Adults. ( 1.2 ) 1.1 Treatment Of Restless Legs Syndrome Horizant ® Is Indicated For The Treatment Of Moderate-To-Severe Primary Restless Legs Syndrome (Rls) In Adults. Horizant Is Not Recommended For Patients Who Are Required To Sleep During The Daytime And Remain Awake At Night. 1.2 Management Of Postherpetic Neuralgia Horizant Is Indicated For The Management Of Postherpetic Neuralgia (Phn) In Adults.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Gabapentin Enacarbil GABAPENTIN ENACARBIL ZINC1554010

Comments